South Nassau Dermatology — Oceanside, New York

South Nassau Dermatology is a clinical research site located in Oceanside, New York, United States 11572.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

South Nassau Dermatology has participated in 1 clinical trials.

Therapeutic areas: Active Non-segmental Vitiligo.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oceanside

Browse all research sites in New York · View every site in Oceanside

• South Nassau Communities Hospital
• Ophthalmic Consultants of Long Island
• Mount Sinai South Nassau
• Ophthalmic Cons of Long Island
• South Nassau Communities
• Ocli Vision
• Ophthalmic Consultants Long Island /ID# 240211
• South Nassau Dermatology /ID# 17065
• TrialSpark, Inc (Russell Cohen)
• OCLI Research Department (01-007)
• Oceanside, NY
• South Nassau Dermatology, P.C.

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Nassau Dermatology?

South Nassau Dermatology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Nassau Dermatology conducted?

South Nassau Dermatology has 1 clinical trials on record. Their work covers Active Non-segmental Vitiligo.

Is South Nassau Dermatology accredited by Crixeo Clinical Trials?

South Nassau Dermatology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Nassau Dermatology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.